CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentPharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Research and development of a novel cancer therapy
Research and development of a cell-biological therapy for cancer and autoimmune diseases; preclinical and translational work, patents, proof of concept and preparation of a clinical study.
Development of a therapy to inhibit metastasis and chemoresistance
Development of a mechanism of action designed to block the interaction between tumour cells and blood platelets, prevent tumour growth and metastasis, and reduce chemoresistance.
Development of a therapy for autoimmune diseases
Development of an approach to counter pathological immune responses in autoimmune diseases, derived from the same cell-growth and signalling mechanism as the oncology application.
Licensing and exploitation of patents
Maintenance and exploitation of medical process patents and other intellectual property rights for use in clinical oncology and related applications.
Knowledge
No knowledge articles yet
Once CELL RECEPTOR SA has claimed this profile, we'll publish editorial articles and case studies here together.